Suppr超能文献

围手术期使用普萘洛尔治疗牙科焦虑症:一项随机对照试验。

Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial.

作者信息

Steenen Serge A, Su Naichuan, van Westrhenen Roos, van Wijk Arjen J, Tjia Daniël S L, de Lange Jan, de Jongh Ad

机构信息

Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Centers/Academic Center for Dentistry (ACTA), University of Amsterdam, Amsterdam, Netherlands.

Department of Oral Public Health, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, Netherlands.

出版信息

Front Psychiatry. 2022 Feb 21;13:842353. doi: 10.3389/fpsyt.2022.842353. eCollection 2022.

Abstract

BACKGROUND

Promising results from a trauma reactivation study on post-traumatic stress disorder suggest that propranolol is capable of attenuating symptoms of traumatically induced mental disorders by blocking memory reconsolidation.

METHODS

A randomized, parallel, placebo-controlled, quadruple-blind trial was designed to determine the effectiveness of perioperative propranolol during exposure to dental extractions in reducing dental anxiety in patients with dental anxiety or dental phobia. Between November 2014 and December 2018, 52 patients with high levels of fear in anticipation of dental extractions who were referred to a department of oral and maxillofacial surgery for at least two tooth and/or molar removals with 1 month in between were included. On the first visit participants received either 120 mg of perioperative oral propranolol ( = 19) or placebo ( = 17), and a core fear memory was reactivated 1 h preoperatively. The primary outcome was change in severity of dental anxiety from baseline to 1-month follow-up, as indexed by the short version of the dental anxiety inventory (S-DAI). Secondary outcome measures were change in intra-operative state anxiety and specific phobia diagnoses.

RESULTS

Linear mixed model (LMM) yielded no statistically significant difference in change of dental trait anxiety from baseline to 1-month follow-up between propranolol and placebo groups (Cohen's = 0.23). S-DAI scores decreased in both study arms from baseline to follow-up (propranolol arm: from 32.1 [SD = 7.3] to 29.1 [SD = 8.8]; placebo arm: from 31.6 [SD = 7.5] to 27.1 [SD = 6.5]). Also, administering propranolol was not associated with a significant difference in change of intra-operative state anxiety or phobia diagnoses between groups over time.

CONCLUSIONS

The results do not concur with earlier findings regarding post-traumatic stress disorder, and suggest that individuals with traumatically induced fears or phobias do not benefit from the application of perioperative propranolol.

摘要

背景

一项关于创伤后应激障碍的创伤再激活研究取得了有前景的结果,表明普萘洛尔能够通过阻断记忆再巩固来减轻创伤性诱发精神障碍的症状。

方法

设计了一项随机、平行、安慰剂对照、四重盲法试验,以确定围手术期使用普萘洛尔在拔牙过程中对减轻牙科焦虑或牙科恐惧症患者牙科焦虑的有效性。在2014年11月至2018年12月期间,纳入了52名预期拔牙时恐惧程度较高的患者,这些患者被转介至口腔颌面外科,计划在1个月内至少拔除两颗牙齿和/或磨牙。在首次就诊时,参与者接受120mg围手术期口服普萘洛尔(n = 19)或安慰剂(n = 17),并在术前1小时重新激活核心恐惧记忆。主要结局是从基线到1个月随访时牙科焦虑严重程度的变化,以牙科焦虑量表简版(S-DAI)为指标。次要结局指标是术中状态焦虑的变化和特定恐惧症诊断。

结果

线性混合模型(LMM)显示,从基线到1个月随访,普萘洛尔组和安慰剂组之间牙科特质焦虑的变化无统计学显著差异(科恩d = 0.23)。两个研究组的S-DAI评分从基线到随访均有所下降(普萘洛尔组:从32.1[标准差 = 7.3]降至29.1[标准差 = 8.8];安慰剂组:从31.6[标准差 = 7.5]降至27.1[标准差 = 6.5])。此外,随着时间推移,给予普萘洛尔与两组之间术中状态焦虑变化或恐惧症诊断的显著差异无关。

结论

这些结果与早期关于创伤后应激障碍的研究结果不一致,表明创伤性诱发恐惧或恐惧症的个体未从围手术期使用普萘洛尔中获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5dd/8899208/d88e3741e6e1/fpsyt-13-842353-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验